2024-10-17T09:01:40-05:00 2023-12-31 861065772 DELOITTE TAX LLP 695 TOWN CENTER DRIVE SUITE 1000 COSTA MESA CA 92626 990 2023-01-01 980593375 GAVI ALLIANCE GAVI 2024781050 CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 FRANCOIS NOTE CHIEF FINANCIAL OFFICER 2024781050 2024-10-15 1 0 JOHN W SADOFF JR P00540589 7144367100 2024-10-15 2023 2024-10-15 13:58:12Z GAVI THE VACCINE ALLIANCE FRANCOIS NOTE CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 2794200261 0 X GAVI.ORG X 2009 SZ TO SAVE LIVES & PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 32 32 20 53 0 0 4419094530 2270153588 0 0 98119459 351162977 -136440227 8894106 4380773762 2630210671 7206568867 3524403694 0 0 70723075 85323553 0 0 32649434 77019732 99872542 7354311674 3709599789 -2973537912 -1079389118 11345377448 10301246567 2962819265 2805930145 8382558183 7495316422 X TO SAVE LIVES AND PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 0 1 2382797155 2296239051 THE VACCINE GOAL: INTRODUCE AND SCALE UP VACCINESWITH THE EXCEPTION OF PENTAVALENT VACCINE, IN AGGREGATE ALL GAVI-SUPPORTED VACCINES HAD HIGHER COVERAGE IN 2023 THAN BEFORE THE PANDEMIC IN 2019.- 34 GAVI-SUPPORTED VACCINE INTRODUCTIONS AND PREVENTIVE CAMPAIGNS TOOK PLACE IN 2023 IN ADDITION TO 40 OUTBREAK RESPONSE VACCINATION CAMPAIGNS SUPPORTED BY GAVI.- 14 MILLION GIRLS FULLY IMMUNIZED AGAINST HPV WITH GAVI SUPPORT IN 2023 MORE THAN THE PREVIOUS TEN YEARS COMBINED.- 15 COUNTRIES ACCESSED CHOLERA, MENINGOCOCCAL AND YELLOW FEVER VACCINES THROUGH GAVI-SUPPORTED EMERGENCY STOCKPILES A TOTAL OF 29 TIMES IN 2023.- 57 GAVI-SUPPORTED COUNTRIES INCREASED BREADTH OF PROTECTION WITH VACCINES IN THE GAVI PORTFOLIO TO 56%, UP 3 PERCENTAGE POINTS FROM 2022.THE EQUITY GOAL: STRENGTHEN HEALTH SYSTEMS TO INCREASE EQUITY IN IMMUNIZATIONIN GAVI 5.0/5.1, HEALTH SYSTEM STRENGTHENING (HSS) SUPPORT PRIORITIZES EQUITY IN IMMUNISATION DELIVERY, TO REDUCE THE NUMBER OF ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN.- >69 MILLION CHILDREN WERE REACHED WITH GAVI-SUPPORTED ROUTINE VACCINES IN 2023 MORE THAN IN ANY YEAR APART FROM 2019.- 47 COUNTRIES HAVE INSTALLED MORE THAN 67,000 COLD CHAIN EQUIPMENT (CCE) UNITS PROCURED BY UNICEF SUPPLY DIVISION THROUGH GAVI'S COLD CHAIN EQUIPMENT OPTIMIZATION PLATFORM (CCEOP) NEARLY 5,200 IN 2023 ALONE.- AFTER SEVERAL YEARS OF DECLINE SINCE 2019, AVERAGE COVERAGE OF DTP3 IN 26 LOW-INCOME COUNTRIES SUPPORTED BY GAVI HELD STEADY IN 2023 THE ONLY INCOME GROUP TO AVOID DECLINE.- 32 COUNTRIES WERE APPROVED FOR EQUITY ACCELERATOR FUND (EAF) FUNDING TO IDENTIFY AND REACH ZERO-DOSE CHILDREN AND MISSED COMMUNITIES.- IN 2023, GAVI-SUPPORTED COUNTRIES MAINTAINED DTP3 COVERAGE AT 80% (COMPARED TO THE 84% GLOBAL AVERAGE).THE SUSTAINABILITY GOAL: IMPROVE SUSTAINABILITY OF NATIONAL IMMUNIZATION PROGRAMSTHE YEAR 2023 CONFIRMED THE ROBUSTNESS OF THE VACCINE ALLIANCE'S CO-FINANCING APPROACH AND THE STEADY FINANCIAL COMMITMENT OF COUNTRIES, DESPITE MANY COUNTRIES FACING INCREASING FRAGILITY.- US$ 215 MILLION WAS CONTRIBUTED BY COUNTRIES TOWARDS THE CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2023 THE HIGHEST AMOUNT YET AND A TESTAMENT TO COUNTRY OWNERSHIP AND THE LONG-TERM FINANCIAL SUSTAINABILITY OF GAVI-SUPPORTED VACCINES.- 55 VACCINE PROGRAMS ORIGINALLY INTRODUCED WITH GAVI FUNDING ARE NOW SELF-FINANCED BY COUNTRIES AS OF 2023, UP FROM 40 IN 2018.- 100% OF COUNTRIES FULLY MET THEIR 2023 CO-FINANCING OBLIGATION EXCEPT FOUR WAIVERS FOR HUMANITARIAN CRISIS.- IN THE FACE OF FISCAL CHALLENGES, CLIMATE CHANGE, CONFLICT AND INSTABILITY, MOST GAVI-SUPPORTED COUNTRIES MAINTAINED OR INCREASED DOMESTIC RESOURCES FOR CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2023, BRINGING TO US$ 1.7 BILLION THEIR TOTAL CONTRIBUTION SINCE THE INTRODUCTION OF THE CO-FINANCING POLICY IN 2008.THE HEALTHY MARKETS GOAL: ENSURE HEALTHY MARKETS FOR VACCINES AND RELATED PRODUCTSGAVI'S MARKET SHAPING EFFORTS MAKE LIFE-SAVING VACCINES AND OTHER IMMUNISATION PRODUCTS MORE ACCESSIBLE AND AFFORDABLE FOR LOWER-INCOME COUNTRIES.- 10 MARKETS FOR VACCINES AND IMMUNISATION PRODUCTS EXHIBITED ACCEPTABLE LEVELS OF HEALTHY MARKET DYNAMICS IN 2023, MEETING THE TARGET FOR THE YEAR.- 10 INNOVATIVE PRODUCTS WERE WITHIN THE PIPELINE OF COMMERCIAL-SCALE MANUFACTURERS IN 2023, CONTINUING TO EXCEED THE ALLIANCE TARGET OF 8 BY 2025 WELL AHEAD OF SCHEDULE..- 1 NEW PRODUCT WITH IMPROVED CHARACTERISTICS WAS NEWLY OFFERED TO GAVI-SUPPORTED COUNTRIES IN 2023, KEEPING THE ALLIANCE ON TRACK FOR ITS 2025 TARGET: MULTIVALENT MENINGOCOCCAL CONJUGATE VACCINE (MMCV), THE FIRST CONJUGATE VACCINE TO PROTECT AGAINST THE FIVE PREDOMINANT SEROGROUPS OF MENINGOCOCCAL MENINGITIS IN AFRICA.- THROUGH GAVI'S MARKET SHAPING EFFORTS, THE NUMBER OF MANUFACTURERS SUPPLYING PREQUALIFIED GAVI-SUPPORTED VACCINES REMAINED AT 19 IN 2023 (WITH MORE THAN HALF BASED IN LOW- AND MIDDLE-INCOME COUNTRIES) COMPARED WITH 5 IN 2001.FURTHER INFORMATION ON GAVI'S PROGRESS TOWARDS ACHIEVING ITS STRATEGIC GOALS CAN BE FOUND IN ITS 2023 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 1244828953 1228164643 COVAX CLOSED ON 31 DECEMBER 2023, AFTER HAVING DELIVERED NEARLY 2 BILLION COVID-19 VACCINE DOSES AND SAFE INJECTION DEVICES TO 146 ECONOMIES, AND IS ESTIMATED TO HAVE AVERTED OVER 2.7 MILLION DEATHS IN AMC LOWER-INCOME PARTICIPATING ECONOMIES. COVAX SUPPLIED 74% OF LOW-INCOME COUNTRIES' COVID-19 VACCINE DOSES DURING THE PANDEMIC; AND IN TOTAL, 54 OF THE 92 AMC-ELIGIBLE ECONOMIES RELIED ON COVAX FOR MORE THAN HALF OF THEIR COVID-19 VACCINE SUPPLY. COVAX HELPED LOWER-INCOME COUNTRIES ACHIEVE TWO-DOSE COVERAGE OF 57%, COMPARED TO THE GLOBAL AVERAGE OF 67%; AND PROTECT HIGH-RISK POPULATIONS: 85% OF HEALTH CARE WORKERS AND 72% OF OLDER ADULTS (COMPARED TO HIGH-INCOME COUNTRIES AT 89% AND 95%, RESPECTIVELY).FURTHER INFORMATION ON GAVI'S COVAX REPORT CAN BE FOUND IN ITS 2023 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 3627626108 1 1 0 1 0 0 0 0 0 0 1 1 0 1 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 X 65 0 1 20 1 0 1 SZ NO EI LU 0 0 0 0 0 0 0 0 0 0 X 32 32 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X FRANCOIS NOTE 2024781050 40 CHEMIN DU POMMIER GRANDSACONNEX GENEVA SZ 1218 X JOSE MANUEL BARROSO CHAIR 2.00 0.00 X 0 0 0 SARAH GOULDING VICE CHAIR - UNTIL 12/23 2.00 0.00 X 0 0 0 OMAR ABDI BOARD MEMBER 2.00 0.00 X 0 0 0 KWAKU AGYEMAN-MANU BOARD MEMBER 2.00 0.00 X 0 0 0 TAKESHI AKAHORI BOARD MEMBER 2.00 0.00 X 0 0 0 BETH ARTHY BOARD MEMBER 2.00 0.00 X 0 0 0 ANAHIT AVANYESAN BOARD MEMBER 2.00 0.00 X 0 0 0 BRUCE AYLWARD BOARD MEMBER - AS OF 02/23 2.00 0.00 X 0 0 0 MAHIMA DATLA BOARD MEMBER - UNTIL 06/23 2.00 0.00 X 0 0 0 GABRIELLA FESUS BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 AAMER IKRAM BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 ZSUZANNA JAKAB BOARD MEMBER - UNTIL 02/23 2.00 0.00 X 0 0 0 ROBERT LUCIEN KARGOUGOU BOARD MEMBER 2.00 0.00 X 0 0 0 NAGUIB KHERAJ BOARD MEMBER 2.00 0.00 X 0 0 0 MANSUKH MANDAVIYA BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 VIOLAINE MITCHELL BOARD MEMBER 2.00 0.00 X 0 0 0 SAAD OMER BOARD MEMBER 2.00 0.00 X 0 0 0 ANDREW DREW OTOO BOARD MEMBER 2.00 0.00 X 0 0 0 SAI PRASAD BOARD MEMBER - AS OF 07/23 2.00 0.00 X 0 0 0 MPHU RAMATLAPENG BOARD MEMBER 2.00 0.00 X 0 0 0 TERESA RESSEL BOARD MEMBER 2.00 0.00 X 0 0 0 JOHN-ARNE ROTTINGEN BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 AWA MARIE COLL SECK BOARD MEMBER 2.00 0.00 X 0 0 0 ANNE SHUCHAT BOARD MEMBER 2.00 0.00 X 0 0 0 DEENA SHIFF BOARD MEMBER 2.00 0.00 X 0 0 0 JUAN PABLO URIBE BOARD MEMBER 2.00 0.00 X 0 0 0 RAFAEL VILASANJUAN BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 YIBING WU BOARD MEMBER 2.00 0.00 X 0 0 0 SOLEH AYUBI ALT. BOARD MEMBER - AS OF 10/23 2.00 0.00 X 0 0 0 EDNA YOLANI BATRES ALT. BOARD MEMBER - UNTIL 02/23 2.00 0.00 X 0 0 0 JOAN BENSON ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 KARIN BERLIN ALT. BOARD MEMBER - 10/23 TO 12/23 2.00 0.00 X 0 0 0 WON DO-YEON ALT. BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 JEREMIE FORRAT-JAIME ALT. BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 ATUL GAWANDE ALT. BOARD MEMBER - 06/23 TO 12/23 2.00 0.00 X 0 0 0 MELLISSA HISKO ALT. BOARD MEMBER - AS OF 06/23 2.00 0.00 X 0 0 0 MOHAMED JAMA ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 JORIS JURRIENS ALT. BOARD MEMBER - UNTIL 06/23 2.00 0.00 X 0 0 0 ETLEVA KADILLI ALT. BOARD MEMBER - UNTIL 06/23 2.00 0.00 X 0 0 0 SILVIA LUTUCUTA ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 BVUDZAI MAGADZIRE ALT. BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 FRANCESCA MANNO ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 ALAA MURABIT ALT. BOARD MEMBER - UNTIL 02/23 2.00 0.00 X 0 0 0 KATE O'BRIEN ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 LEILA GHARAGOZLOO PAKKALA ALT. BOARD MEMBER - AS OF 10/23 2.00 0.00 X 0 0 0 BOUNFENG PHOUMMALAYSITH ALT. BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 MICHAEL KENT RANSON ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 EDUARDO HUMBERTO RETES ALT. BOARD MEMBER - AS OF 05/23 2.00 0.00 X 0 0 0 XIANG SHU ALT. BOARD MEMBER - UNTIL 08/23 2.00 0.00 X 0 0 0 JOSHUA TABAH ALT. BOARD MEMBER - UNTIL 06/23 2.00 0.00 X 0 0 0 LIA TADESSE ALT. BOARD MEMBER - UNTIL 12/23 2.00 0.00 X 0 0 0 RHODA WANYENZE ALT. BOARD MEMBER 2.00 0.00 X 0 0 0 GREG WIDMYER ALT. BOARD MEMBER - AS OF 02/23 2.00 0.00 X 0 0 0 DR SETH BERKLEY CEO - UNTIL 08/23 39.10 0.90 X 510162 0 80673 DAVID MARLOW INTERIM CEO - AS OF 09/23 37.50 2.50 X 447107 0 80526 BRENDA KILLEN DIRECTOR, GOVERNANCE 32.50 7.50 X 242083 0 61497 ASSIETOU DIOUF CHIEF FINANCIAL OFFICER 37.50 2.50 X 238660 0 63539 THABANI MAPHOSA MANAGING DIR, COUNTRY PROGRAMMES 40.00 0.00 X 268012 0 72118 PASCAL BAROLLIER CHIEF ENG. AND INFORMATION OFFICER 40.00 0.00 X 280998 0 91218 MARIE-ANGE SARAKA-YAO CHIEF RES. MOB. AND GROWTH OFFICER 40.00 0.00 X 297200 0 70403 AURELIA NGUYEN MNG DIRECTOR CHIEF PROGRAMME OFFICER 40.00 0.00 X 291349 0 74483 DERRICK SIM MANAGING DIR. OFFICE OF COVAX FAC. 40.00 0.00 X 229397 0 71837 CATHERINE PAWLOW DIRECTOR, HUMAN RESOURCES 40.00 0.00 X 536878 0 66467 SUSAN MACKAY HEAD, DEMAND, COMMUNITIES & GENDER 40.00 0.00 X 368598 0 23838 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 40.00 0.00 X 306477 0 67373 ALEX DE JONQUIERES DIRECTOR, HEALTH SYSTEMS AND IMMUN. 40.00 0.00 X 299179 0 68165 ANDREW MENDS DIRECTOR OPERATION AND PROCUREMENT 40.00 0.00 X 290203 0 67017 4606303 0 959154 334 0 1 0 HELVETIC PAYROLL SA RUE DU SAUSANNE 44 GENEVA SZ 1201 TEMPORARY STAFFING (SALARY HOSTING) 6638165 TECH MAHINDRA LIMITED OFF KARVE ROAD PUNE IN 411004 IT SERVICES 5984697 LINKLATERS LLP ONE SILK STREET LONDON UK EC2Y 8HQ LEGAL SERVICES 2691045 THE BOSTON CONSULTING GROUP AND CIE 24-26 RUE SAINT DOMINIQUE PARIS FR 75007 CONSULTING SERVICES 2041035 MICHAEL PAGE INTERNATIONAL SUISSE QUAI DE LA POSTE 12 GENEVA SZ 1204 TEMPORARY STAFFING 2030114 208 377735536 1862274293 30143759 309627599 2270153588 349559545 349559545 165565105 27917 163989590 0 1575515 27917 1603432 1603432 OTHER REVENUE 900099 5029373 5029373 FC TRANSLATION ADJ. 900099 3864733 3864733 8894106 2630210671 0 0 360057083 125267680 125267680 3399136014 3399136014 3471262 2053250 920233 497779 54789696 32406833 14527688 7855175 11477990 6788966 3043428 1645596 14159658 8375122 3754455 2030081 1424947 842825 377826 204296 1261895 1261895 713382 713382 277200 277200 5257297 5257297 60428027 33845015 11886320 14696692 893025 377081 11848 504096 6870007 4402475 1523975 943557 4294950 2882641 805545 606764 4828119 3093981 1071023 663115 7517093 5352950 851823 1312320 4394851 1350396 1606040 1438415 1065059 682517 236262 146280 766452 491162 170022 105268 TRAINING & RECRUITMENT 1305185 1305185 3709599789 3627626108 49324247 32649434 X 42084146 28382599 7709281 5992266 19778047 14300731 6886494482 6808004210 1961055637 1506164534 611549794 154105390 9424561 7969530 2211826 1455031 1028190736 1301455921 836096926 515760750 11345377448 10301246567 50376809 230456601 36793003 463446843 873650200 1067371453 2001999253 1044655248 2962819265 2805930145 X 2172353383 1761702186 6210204800 5733614236 8382558183 7495316422 11345377448 10301246567 X -1079389118 137155578 54991779 X 0 1 X 1 0 X 800186577 2433703395 16367570660 4419094530 2270153588 26290708750 800186577 2433703395 16367570660 4419094530 2270153588 26290708750 3537164223 22753544527 31105860 16200090 11257940 93043467 349559545 501166902 274962 27180 186856 6746 5029373 5525117 26797400769 0.84910 0.85990 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2019 AMOUNT: $ 266,165. 2020 AMOUNT: $ 27,180. 2021 AMOUNT: $ 186,856. 2022 AMOUNT: $ 6. 2023 AMOUNT: $ 5,029,373. PARKING INCOME - 2019 AMOUNT: $ 8,797. TAX REFUND - 2022 AMOUNT: $ 6,740. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 277200 0 0 277200 0 PART II-B, LINE 1: FEES WERE PAID FOR: 1. PRESENTATION AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF OF THE HOUSE AND SENATE COMMITTEES ON APPROPRIATIONS, AND ANY OTHER COMMITTEES NEEDED, TO REQUEST SUPPORT FOR THE GAVI ALLIANCE; AND 2. SUPPORT AND GUIDANCE TO GAVI ALLIANCE IN POSITIONING THE ORGANIZATION WITH THE ADMINISTRATION, AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF ON VARIOUS COMMITTEES. 1334586 1009258 325328 1427590 878655 548935 6662385 6081617 580768 1455031 LIMITED LIABILITY COMPANIES AND LIMITED PARTNERSHIPS 720874189 F REGISTERED INVESTMENT COMPANIES 580581732 F 1301455921 CURRENCY FORWARD CONTRACTS 77556753 DUE FROM GAVI AFFILIATES 149685 OPERATING LEASE RIGHT OF USE ASSET 9194842 RECEIVABLE ON COVAX FACILITY ARRANGEMENTS 400800 OTHER ASSETS 21097296 INTEREST INCOME CLEARING ACCOUNT 12225111 RECEIVABLES FROM VACCINE MANUFACTURERS 395136263 515760750 PROCUREMENT ACCOUNTS PAYABLE 601820532 PAYABLE ON COVAX FACILITY ARRANGEMENTS 357607162 REFUNDABLE ADVANCE 61602179 OPERATING LEASE OBLIGATION 11438664 FOREIGN CURRENCY FORWARD CONTRACTS PAYABLE 12186711 1044655248 X PART X, LINE 2: GAVI IS EXEMPT FROM INCOME TAXES IN EACH OF THE JURISDICTIONS IN WHICH IT HAS OPERATIONS. US GAAP REQUIRES THAT FINANCIAL STATEMENTS REFLECT THE EXPECTED FUTURE TAX CONSEQUENCES OF UNCERTAIN TAX POSITIONS THAT AN ENTITY HAS TAKEN OR EXPECTS TO TAKE ON A TAX RETURN, PRESUMING THE TAX AUTHORITIES' FULL KNOWLEDGE OF THE POSITION AND ALL RELEVANT FACTS. US GAAP ALSO REQUIRES THAT AN ENTITY RECOGNISES THE BENEFIT OF TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT THAT THE PROVISION WILL BE SUSTAINABLE BASED ON THE MERITS OF THE POSITION. GAVI PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEARS ENDED 31 DECEMBER 2023 AND 2022 AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR WHICH MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. AS OF 31 DECEMBER 2023, THE STATUTES OF LIMITATIONS FOR TAX YEARS 2020 THROUGH 2022 REMAIN OPEN WITH THE UNITED STATES FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH GAVI FILES TAX RETURNS. IT IS GAVI'S POLICY TO RECOGNISE INTEREST OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSE. AS OF 31 DECEMBER 2023 AND 2022, GAVI HAD NO ACCRUED INTEREST OR PENALTIES. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 153271096 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 1952825259 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 407969630 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 82970326 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 84698773 RUSSIA AND NEIGHBORING STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 106593138 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 43380757 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 32361343 VARIOUS REGIONS 0 0 GRANTS TO RECIPIENTS LOCATED IN VARIOUS REGIONS 535065698 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 INVESTMENTS 7310611412 EUROPE (INCLUDING ICELAND & GREENLAND) 1 391 PROGRAM SERVICES COUNTRY PROGRAMMES MGMT. & OVERSIGHT, POLICY & PERFORMANCE, AND OPERATIONS 103222414 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 FUNDRAISING 32649434 0 0 1 391 1 391 2864070322 7981548958 10845619280 VARIOUS REGIONS COUNTRY PROGRAMMES 517048032 BOARD APPROVAL/WIRE TRANSFER 18017666 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 8000000 BOARD APPROVAL/WIRE TRANSFER 16287006 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 1427560 BOARD APPROVAL/WIRE TRANSFER 1966735 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 173365 VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 45773 COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 221817 COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 5939876 BOARD APPROVAL/WIRE TRANSFER 9207114 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 111510 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC WORK PLAN 67953 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 408327 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 46740 BOARD APPROVAL/WIRE TRANSFER 18709022 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC WORK PLAN 41456 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 458783 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 725269 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 917468 BOARD APPROVAL/WIRE TRANSFER 1230309 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC WORK PLAN 939809 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 633266 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 8214388 BOARD APPROVAL/WIRE TRANSFER 13410560 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 202486 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC WORK PLAN 7212216 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 61626 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 3659960 BOARD APPROVAL/WIRE TRANSFER 2170842 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 15000000 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 5415080 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 2828739 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 464920 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 151106 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 299386 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 286189 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 261341 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 257810 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 241898 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 193258 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 169291 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 33723973 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 126419 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 107000 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 259072 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 2032470 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 500000 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 473796 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 503668 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 544775 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 580133 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 841487 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 917338 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 105907 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 941651 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1004391 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1324945 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1829596 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1956465 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 4815872 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 98312412 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 88281 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 39880 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 67499 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 23570 COVAX VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 46217 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 27438 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 81116 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 61937 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 68400 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 14253 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 9354 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 66759 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 11740 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 48865 BOARD APPROVAL/WIRE TRANSFER 0 FMV MIDDLE EAST AND NORTH AFRICA WORK PLAN 54046 BOARD APPROVAL/WIRE TRANSFER 0 FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 2114708 VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 14539909 BOARD APPROVAL/WIRE TRANSFER 23645722 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 23686327 BOARD APPROVAL/WIRE TRANSFER 20658062 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 0 34096 VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 3816602 BOARD APPROVAL/WIRE TRANSFER 11552714 VACCINE SUPPORT, COLD CHAIN EQUIPMENT , COVAX VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 0 146560 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 3382774 BOARD APPROVAL/WIRE TRANSFER 82457733 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 2704822 BOARD APPROVAL/WIRE TRANSFER 2497838 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH AMERICA WORK PLAN 63213 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH AMERICA COUNTRY PROGRAMMES 0 25340081 VACCINE SUPPORT FMV SOUTH AMERICA COUNTRY PROGRAMMES 1450406 BOARD APPROVAL/WIRE TRANSFER 4994709 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH AMERICA COUNTRY PROGRAMMES 0 512935 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 4812099 BOARD APPROVAL/WIRE TRANSFER 34579246 VACCINE SUPPORT, COLD CHAIN EQUIPMENT , COVAX VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 1027429 BOARD APPROVAL/WIRE TRANSFER 100796956 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH ASIA WORK PLAN 547899 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 0 1092196 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH ASIA WORK PLAN 1380669 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 1224791 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 206588 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 22782450 BOARD APPROVAL/WIRE TRANSFER 64566788 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 46437305 BOARD APPROVAL/WIRE TRANSFER 774091 VACCINE SUPPORT FMV SOUTH ASIA WORK PLAN 116750 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 20696595 BOARD APPROVAL/WIRE TRANSFER 106426374 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SOUTH ASIA WORK PLAN 106215 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 100000 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 204366 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 90823 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 53124480 BOARD APPROVAL/WIRE TRANSFER 217649916 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 86759918 BOARD APPROVAL/WIRE TRANSFER 158641121 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 50362054 BOARD APPROVAL/WIRE TRANSFER 181608324 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2302617 BOARD APPROVAL/WIRE TRANSFER 2195612 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2186381 BOARD APPROVAL/WIRE TRANSFER 28848125 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 34509993 BOARD APPROVAL/WIRE TRANSFER 68318443 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 10265538 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 24639143 BOARD APPROVAL/WIRE TRANSFER 45151797 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4404509 BOARD APPROVAL/WIRE TRANSFER 7172327 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4775085 BOARD APPROVAL/WIRE TRANSFER 2934257 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2099569 BOARD APPROVAL/WIRE TRANSFER 6927531 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2528370 BOARD APPROVAL/WIRE TRANSFER 974490 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3315146 BOARD APPROVAL/WIRE TRANSFER 20739621 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12830739 BOARD APPROVAL/WIRE TRANSFER 32033877 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5643156 BOARD APPROVAL/WIRE TRANSFER 47860748 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 50187 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 15318284 BOARD APPROVAL/WIRE TRANSFER 2491925 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12749628 BOARD APPROVAL/WIRE TRANSFER 61143915 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 15524179 BOARD APPROVAL/WIRE TRANSFER 29967607 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 15922877 BOARD APPROVAL/WIRE TRANSFER 13957859 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 10549914 BOARD APPROVAL/WIRE TRANSFER 26998437 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 10281876 BOARD APPROVAL/WIRE TRANSFER 30939089 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 8436190 BOARD APPROVAL/WIRE TRANSFER 17168302 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 14051996 BOARD APPROVAL/WIRE TRANSFER 45334649 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 16603303 BOARD APPROVAL/WIRE TRANSFER 7137959 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 284023 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7278707 BOARD APPROVAL/WIRE TRANSFER 22615255 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17860208 BOARD APPROVAL/WIRE TRANSFER 52364510 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6783250 BOARD APPROVAL/WIRE TRANSFER 13134698 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6695474 BOARD APPROVAL/WIRE TRANSFER 31856112 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6073718 BOARD APPROVAL/WIRE TRANSFER 11478569 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6006990 BOARD APPROVAL/WIRE TRANSFER 8605992 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 19189683 BOARD APPROVAL/WIRE TRANSFER 45404662 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 16841847 BOARD APPROVAL/WIRE TRANSFER 48930819 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 11866970 BOARD APPROVAL/WIRE TRANSFER 7788874 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 81578 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1900362 BOARD APPROVAL/WIRE TRANSFER 419223 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 381635 BOARD APPROVAL/WIRE TRANSFER 4246442 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 379117 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 373419 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 355096 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 330462 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 327250 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 317539 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 52936 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 54945 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 60000 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 216820 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 206900 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 161256 BOARD APPROVAL/WIRE TRANSFER 2492181 VACCINE SUPPORT, COLD CHAIN EQUIPMENT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 153383 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 150000 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 134342 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 125368 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 124552 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 74052 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 74400 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 77850 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 35998 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 482521 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 23119 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 22443 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1871425 BOARD APPROVAL/WIRE TRANSFER 80637179 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 1331467 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1307975 BOARD APPROVAL/WIRE TRANSFER 1686875 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1273413 BOARD APPROVAL/WIRE TRANSFER 966205 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1148768 BOARD APPROVAL/WIRE TRANSFER 8332896 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 9000 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 9813 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 919254 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 13393 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1932377 BOARD APPROVAL/WIRE TRANSFER 252042 VACCINE SUPPORT , COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 842402 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 781549 BOARD APPROVAL/WIRE TRANSFER 6734712 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC FMV SUB-SAHARAN AFRICA WORK PLAN 16226 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 638738 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 631392 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 629137 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 608163 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 17380 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 567518 BOARD APPROVAL/WIRE TRANSFER 7589657 VACCINE SUPPORT , YELLOW FEVER DIAGNOSTIC, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 20213 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 530312 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 788612 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 409741 BOARD APPROVAL/WIRE TRANSFER 0 FMV 29 154 1 0 0 0 0 1 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT SUPPORT AND PROTECTS AGAINST CORRUPTION AND FRAUD THROUGH COLLABORATION WITH PARTNERS, THROUGH THE MAINTENANCE AND IMPLEMENTATION OF ROBUST POLICIES AND PROCEDURES, GRANT TERMS AND CONDITIONS, AND AN AUDIT AND INVESTIGATIONS FUNCTION. POLICIES AND PROCEDURES: ALL APPLICATIONS FOR NEW SUPPORT, AND REQUESTS FOR CONTINUED SUPPORT, REQUIRE AN ENDORSEMENT AND SIGNATURES FROM A NATIONAL COORDINATION BODY WHICH IN THE CASE OF NEW VACCINES SUPPORT, IS THE INTER-AGENCY COORDINATION COMMITTEE (ICC). THE ICC INCLUDES ON ITS MEMBERSHIP, IN ADDITION TO HIGH LEVEL REPRESENTATION OF THE GOVERNMENT OF GAVI COUNTRIES, GAVI PARTNERS SUCH AS THE WORLD HEALTH ORGANIZATION, UNICEF, NONGOVERNMENTAL ORGANIZATIONS AND DONOR GOVERNMENTS. IN THE CASE OF CASH SUPPORT FOR HEALTH SYSTEM STRENGTHENING, ENDORSEMENT IS REQUIRED FROM THE HEALTH SECTOR COORDINATION COMMITTEE (HSCC) OR OTHER SIMILAR INTER-AGENCY COMMITTEE WHICH ALSO INCLUDES THE GOVERNMENT, BILATERAL, MULTILATERAL AGENCIES AND CIVIL SOCIETY REPRESENTATIVES. - IN ADDITION, THE APPLICATIONS SUBMITTED MUST INCLUDE THE SIGNATURES OF THE MINISTER OF HEALTH AND THE MINISTER OF FINANCE. THE GAVI NEW APPLICATIONS GUIDELINES PROVIDE DETAILS ON GAVI SUPPORT, INCLUDING GENERAL PRINCIPLES AND THE PROCESS FOR APPLYING AND MONITORING ACTIVITIES. A PARTNERSHIP FRAMEWORK AGREEMENT IS ENTERED INTO BETWEEN GAVI AND COUNTRIES THAT SETS OUT THE TERMS AND CONDITIONS GOVERNING GAVI SUPPORT. THE MAIN TOOLS/APPROACHES USED BY GAVI TO MONITOR THE USE OF GAVI SUPPORT ARE THE FOLLOWING: - (1) IN-COUNTRY COORDINATING AND/OR SIMILAR SUPERVISORY COMMITTEES (ICC AND HSCC) AND RELATED TECHNICAL WORKING GROUPS; (2) ROUTINE MONITORING MISSIONS IN-COUNTRY, LED BY SENIOR COUNTRY MANAGERS, WORKING WITH PARTNERS AND IN-COUNTRY COUNTERPARTS AS WELL AS FORMAL ANNUAL JOINT APPRAISALS THAT REVIEW PERFORMANCE OF ALL GRANTS IN-COUNTRY; (3) FOR CASH GRANTS - RISK-BASED PROGRAMME AUDITS BY GAVI AND ANNUAL EXTERNAL AUDITS BY THE COUNTRY IN ADDITION TO QUARTERLY/SEMI ANNUAL FINANCIAL REPORTING REQUIREMENTS. THE EXTERNAL AUDITS AND FINANCIAL REPORTS ARE REVIEWED BY GAVI; (4) MONITORING REVIEWS OF GRANT MANAGEMENT REQUIREMENTS ARISING FROM THE PROGRAMME CAPACITY ASSESSMENTS THAT INDEPENDENTLY ASSESSED FINANCIAL MANAGEMENT ARRANGEMENTS AND PROGRAMMATIC/MANAGEMENT CAPACITIES IN-COUNTRY AS WELL AS INVESTIGATIONS IN CASES OF SUSPECTED OR ACTUAL MISUSE OF FUNDS; (5) STRATEGIC ENGAGEMENT WITH FIRMS (APS) PROVIDING OVERSIGHT & ASSURANCE SERVICES OVER COUNTRY IMPLEMENTATION OF CASH GRANTS. THE ASSURANCE FRAMEWORK PROVIDES MANAGEMENT WITH THE CONFIDENCE THAT GAVI OBEJECTIVES WOULD BE ATTAINED WITHIN GAVI'S RISK APPETITE. (6) ROUTINE REVIEW BY THE SECRETARIAT OR INDEPENTLY CONTRACTED PROVIDERS OF QUANTITATIVE AND QUALITATIVE INFORMATION PROVIDED THROUGH THE MONITORING AND PERFORMACE MANAGEMENT SYSTEM AND JOINT APPRAISALS, AS WELL AS ANY ADDITIONAL REPORTS/EVALUATIONS/SURVEYS/ASSESSMENTS SUBMITTED TO GAVI BY RECIPIENT GOVERNMENTS. (7) HIGH LEVEL MISSIONS IN-COUNTRY, LED BY GAVI CHIEF EXECUTIVE OFFICER, WORKING WITH LEADERS OF ALLIANCE PARTNERS AND IN-COUNTRY COUNTERPARTS AS WELL AS USE OF ACCOUNTABILITY FRAMEWORKS THAT REVIEW IMMUNISATION PROGRAMMING AND FINANCING COMMITMENTS. COLLABORATION WITH PARTNERS: GAVI MAINTAINS FORMAL AND INFORMAL CONTACT WITH THE PARTNERS (THE BILL & MELINDA GATES FOUNDATION, UNICEF, WHO, THE WORLD BANK GROUP, CIVIL SOCIETY ORGANIZATIONS, DEVELOPING COUNTRY GOVERNMENTS, DEVELOPING COUNTRY PHARMACEUTICAL INDUSTRY, INDUSTRIALISED COUNTRY GOVERNMENTS, INDUSTRIALISED COUNTRY PHARMACEUTICAL INDUSTRY, RESEARCH AND TECHNICAL HEALTH INSTITUTES) AT VARIOUS LEVELS TO HELP ENSURE THAT RELEVANT INFORMATION ABOUT SUSPECTED AND ACTUAL CASES OF CORRUPTION AND MISUSE OF FUNDS IS SHARED ON A TIMELY BASIS. - GAVI ENGAGES UNICEF, A KEY PARTNER IN GAVI, THE VACCINE ALLIANCE, FOR THE PURCHASE AND DELIVERY OF VACCINES. UNICEF MANAGES VACCINE LOGISTICS AND DELIVERY IN ACCORDANCE WITH ITS INTERNAL CONTROLS AND INTERNAL AND EXTERNAL AUDITS AS MANDATED BY ITS MEMBER STATES. GAVI AND UNICEF HAVE ENTERED INTO VARIOUS AGREEMENTS WHICH PROVIDE FOR CONFIRMATIONS, ASSURANCES AND INFORMATION REGARDING UNICEF ACTIVITIES CARRIED OUT ON BEHALF OF THE ALLIANCE. AUDIT AND INVESTIGATIONS: THE PRIMARY RESPONSIBILITY OF THE AUDIT AND INVESTIGATIONS FUNCTION IS ASSIST THE MANAGEMENT AND STAKEHOLDERS OF GAVI IN ACCOMPLISHING ITS OBJECTIVES AND TO ENHANCE AND PROTECT ORGANISATIONAL VALUE BY PROVIDING RISK-BASED AND OBJECTIVE ASSURANCE, AND INSIGHT, AND ASSESS PROBITY. THE WORK OF AUDIT AND INVESTIGATIONS EXTENDS NOT ONLY TO THE SECRETARIAT, BUT ALSO TO GAVI-SUPPORTED PROGRAMMES IN-COUNTRY INCLUDING THE FACILITY. AUDIT AND INVESTIGATIONS IS LED BY A MANAGING DIRECTOR WHO REPORTS TO THE BOARD, THROUGH ROUTINE REPORTING TO THE AUDIT AND FINANCE COMMITTEE, AND TO THE CHIEF EXECUTIVE OFFICER. THE TRANSPARENCY AND ACCOUNTABILITY POLICY (TAP): THROUGH TAP, GAVI IS ABLE TO ENSURE THAT ALL GAVI SUPPORT AT COUNTRY LEVEL IS MANAGED IN A TRANSPARENT AND ACCOUNTABLE MANNER THROUGH SYSTEMS THAT INCLUDE APPROPRIATE OVERSIGHT MECHANISMS, AND THAT THE SUPPORT IS USED ACCORDING TO THE PROGRAMME OBJECTIVES AS OUTLINED IN INDIVIDUAL COUNTRY AGREEMENTS. THE POLICY GOVERNS THE TRANSPARENCY AND ACCOUNTABILITY ASPECTS OF GAVI SUPPORT PROVIDED IN THE FORM OF CASH, VACCINES AND VACCINE DEVICES AT COUNTRY LEVEL. THE PRINCIPLES GOVERNING TAP INCLUDE: RESPECT AID EFFECTIVENESS PRINCIPLES; FOCUS ON PREVENTION; RELATE MONITORING TO RISK; PROMOTE FLEXIBILITY AND COUNTRY OWNERSHIP; PROMOTE MUTUAL ACCOUNTABILITY; AND STRENGTHEN COUNTRY SYSTEMS. TAP AIMS TO RETAIN A FLEXIBLE AND NON-PERSPECTIVE APPROACH TO ALLOW FOR DIFFERENCES IN COUNTRY CONTEXT AND ENHANCES CONTINUED EFFORTS BY GAVI TO SUPPORT SUSTAINABLE DEVELOPMENT OF COUNTRY CAPACITY. PART I, LINE 3: THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. PART I, LINE 3, COLUMN (D) RECIPIENTS REFER TO COUNTRIES OR PARTNERS LOCATED IN THE REGION. PART II, LINE 1 THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. 1 CAMPAIGN FOR TOBACCO-FREE KIDS 102 CITY HALL PLAZA 200 DURHAM NC 27701 521969967 501(C)(3) 654105 0 PARTNER SUPPORT CDC 1600 CLIFTON ROAD ATLANTA GA 30303 586051157 CDC 644000 0 PARTNER SUPPORT CDC FOUNDATION 600 PEACHTREE STREET NE SUITE 1000 ATLANTA GA 30303 582106707 501(C)(3) 1199922 0 PARTNER SUPPORT CLINTON HEALTH ACCESS INITIATIVE 383 DORCHESTER AVENUE SUITE 400 BOSTON MA 02127 271414646 501(C)(3) 5763165 0 PARTNER SUPPORT DIMAGI INC 585 MASSACHUSETTS AVENUE SUITE 3 CAMBRIDGE MA 02139 830343298 55000 0 PARTNER SUPPORT FAMILY HEALTH INTERNATIONAL 359 BLACKWELL STREET SUITE 200 DURHAM NC 27701 237413005 501(C)(3) 340225 0 PARTNER SUPPORT GDI SOLUTIONS LLC 1401 K STREET NW SUITE 900 WASHINGTON DC 20005 881343562 501(C)(3) 863844 0 PARTNER SUPPORT GLOBAL IMPACT 199 NORTH FAIRFAX STREET NO 300 ALEXANDRIA VA 22314 521273585 501(C)(3) 6000000 0 PARTNER SUPPORT HARVARD - PRESIDENT AND FELLOWS OF HARVARD COLLEGE 1033 MASSACHUSSETS AVENUE CAMBRIDGE MA 02138 042103580 501(C)(3) 219091 0 PARTNER SUPPORT INTEGRATE HEALTH INC PO BOX 605 MEDWAY MA 02053 134288670 501(C)(3) 500038 0 PARTNER SUPPORT INTERNATIONAL ORGANIZATION FOR MIGRATION 1752 N STREET NW WASHINGTON DC 20036 521525929 501(C)(3) 669260 0 PARTNER SUPPORT JHPIEGO 1615 THAMES STREET BALTIMORE MD 21231 237424444 501(C)(3) 1045708 0 PARTNER SUPPORT JOHNS HOPKINS UNIVERSITY 1101 E33RD STREET SUITE D200 BALTIMORE MD 21218 520595110 501(C)(3) 1665316 0 PARTNER SUPPORT JSI RESEARCH & TRAINING INSTITUTE INC 2733 CRYSTAL DRIVE 4TH FLOOR ARLINGTON VA 22202 042679824 501(C)(3) 6753147 0 PARTNER SUPPORT KATI COLLECTIVE INC 13346 108TH AVENUE SW VASHON WA 98070 843168072 190869 0 PARTNER SUPPORT KHUSHI BABY INC LOUIS WAY EL 6016 DORADO HILLS CA 95762 465767894 501(C)(3) 500000 0 PARTNER SUPPORT MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 021394307 042103594 501(C)(3) 144382 0 PARTNER SUPPORT MASTERCARD INTERNATIONAL INC 200 PURCHASE STREET PURCHASE NEW YORK NY 10577 952536378 378510 0 PARTNER SUPPORT NEXLEAF ANALYTICS 1964 WESTWOOD BOULEVARD LOS ANGELES CA 90025 900514027 501(C)(3) 55974 0 PARTNER SUPPORT PAN AMERICAN SANITARY BUREAU 525 TWENTY-THIRD STEET NW WASHINGTON DC 20037 521804954 PASB 1958666 0 PARTNER SUPPORT PARSYL INC 2714 WALNUT STREET DENVER CO 80205 814027966 300000 0 PARTNER SUPPORT PATH 2201 WESTLAKE AVENUE SEATTLE WA 98109 911157127 501(C)(3) 2883350 0 PARTNER SUPPORT PREMISE DATA CORPORATION 185 BERRY STREET SUITE 6850 SAN FRANCISCO CA 94107 455294131 41474 0 PARTNER SUPPORT RESULTS FOR DEVELOPMENT INSTITUTE 1111 19TH STREET NW SUITE 700 WASHINGTON DC 20036 208530747 501(C)(3) 1072020 0 PARTNER SUPPORT THE GEORGE WASHINGTON UNIVERSITY 45155 RESEARCH PL 260 ASHBURN VA 20147 530196584 501(C)(3) 131347 0 PARTNER SUPPORT THE PENNSYLVANIA STATE UNIVERSITY 201 OLD MAIN UNIVERSITY PARK PA 16802 246000376 40000 0 PARTNER SUPPORT THE DIFFERENCE A2C LLC 661 AUBURN AVENUE NE SUITE 5 ATLANTA GA 30312 261133788 158550 0 PARTNER SUPPORT THE WORLD BANK (IBRD) 1818 H STREET WASHINGTON DC 20433 980002549 THE WORLD BANK 5740372 0 PARTNER SUPPORT UNICEF 333 EAST 38TH STREET NEW YORK NY 10116 131760110 501(C)(3) 81242776 0 PROCUREMENT FEE & PARTNER SUPPORT UNIVERSITY OF WASHINGTON 1400 NE CAMPUS PARKWAY SEATTLE WA 98195 916001537 STATE OF WA 200000 0 PARTNER SUPPORT VILLAGE REACH 2900 EASTLAKE AVE E SUITE 230 SEATTLE WA 98102 912083484 501(C)(3) 2884606 0 PARTNER SUPPORT YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 501(C)(3) 207746 0 PARTNER SUPPORT ZENYSIS TECHNOLOGIES INC 2325 3RD ST NUMBER 213 SAN FRANCISCO CA 94107 810929294 513933 0 PARTNER SUPPORT ZIPLINE INTERNATIONAL INC 495 PINE AVE HALF MOON BAY CA 94019 453197601 250000 0 PARTNER SUPPORT 24 10 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND SUBSEQUENTLY DISBURSED IN GAVI PROGRAMME COUNTRIES AS DESCRIBED IN SCHEDULE F, PART V. ANY GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND USED INSIDE THE US ARE MONITORED THROUGH THE FOLLOWING WAYS: (I) THROUGH, AT MINIMUM, ANNUAL TECHNICAL PROGRESS REPORTS AND CERTIFIED FINANCIAL REPORTS FROM GRANTEES THAT SUPPORT THE ACHIEVEMENT OF MILESTONES STIPULATED IN THE GRANT AGREEMENTS. REPORTS ARE RECEIVED AND REVIEWED BY THE GAVI STAFF BUSINESS OWNER; AND (II) ARE SUBJECT TO GAVI INTERNAL AUDIT AS APPROPRIATE. X X 1 1 X X X 1 0 0 0 0 0 0 0 0 CATHERINE PAWLOW DIRECTOR, HUMAN RESOURCES 250101 0 6252 0 280525 0 55309 0 11158 0 603345 0 0 0 DR SETH BERKLEY CEO - UNTIL 08/23 285442 0 0 0 224720 0 64325 0 16348 0 590835 0 0 0 DAVID MARLOW INTERIM CEO - AS OF 09/23 294107 0 0 0 153000 0 62118 0 18408 0 527633 0 0 0 SUSAN MACKAY HEAD, DEMAND, COMMUNITIES & GENDER 88868 0 0 0 279730 0 18259 0 5579 0 392436 0 0 0 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 237864 0 0 0 68613 0 52135 0 15238 0 373850 0 0 0 PASCAL BAROLLIER CHIEF ENG. AND INFORMATION OFFICER 280998 0 0 0 0 0 63323 0 27895 0 372216 0 0 0 MARIE-ANGE SARAKA-YAO CHIEF RES. MOB. AND GROWTH OFFICER 287657 0 9543 0 0 0 64824 0 5579 0 367603 0 0 0 ALEX DE JONQUIERES DIRECTOR, HEALTH SYSTEMS AND IMMUN. 240816 0 4402 0 53961 0 52927 0 15238 0 367344 0 0 0 AURELIA NGUYEN MNG DIRECTOR CHIEF PROGRAMME OFFICER 287657 0 3692 0 0 0 64824 0 9659 0 365832 0 0 0 ANDREW MENDS DIRECTOR OPERATION AND PROCUREMENT 236242 0 0 0 53961 0 51779 0 15238 0 357220 0 0 0 THABANI MAPHOSA MANAGING DIR, COUNTRY PROGRAMMES 241031 0 0 0 26981 0 53000 0 19118 0 340130 0 0 0 BRENDA KILLEN DIRECTOR, GOVERNANCE 215102 0 0 0 26981 0 46259 0 15238 0 303580 0 0 0 ASSIETOU DIOUF CHIEF FINANCIAL OFFICER 238660 0 0 0 0 0 52381 0 11158 0 302199 0 0 0 DERRICK SIM MANAGING DIR. OFFICE OF COVAX FAC. 229397 0 0 0 0 0 49521 0 22316 0 301234 0 0 0 PART I, LINE 1A UNDER AN AGREEMENT WITH THE SWISS GOVERNMENT, NON-SWISS EMPLOYEES OF THE GAVI ALLIANCE WORKING IN GENEVA, SWITZERLAND ARE EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. AS THE GAVI ALLIANCE IN GENEVA OPERATES AN INTERNAL TAX SCHEME, EMPLOYEES OF SWISS NATIONALITY ARE ALSO EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. TO ENSURE EQUITY AMONGST GAVI EMPLOYEES, CERTAIN ELIGIBLE EMPLOYEES WHO HAVE A FOREIGN TAX LIABILITY ON THEIR GAVI SALARY AND ALLOWANCES (E.G. US NATIONALS AND EMPLOYEES LIVING IN FRANCE) MAY RECEIVE ASSISTANCE FROM GAVI IN MEETING THEIR TAX OBLIGATIONS IN ACCORDANCE WITH GAVI'S FOREIGN TAX POLICY. IN ADDITION, FOR THE YEAR ENDED DECEMBER 31, 2023, THE CHIEF EXECUTIVE OFFICER RECEIVED A HOUSING ALLOWANCE OF CHF 10,600 WHICH WAS TREATED AS TAXABLE COMPENSATION. PART I, LINE 4A DURING THE YEAR ENDED DECEMBER 31, 2023, SEVERANCE WAS PAID TO CATHERINE PAWLOW, DIRECTOR, HUMAN SERVICES, IN THE AMOUNT OF $345,681, AND TO SUSAN MACKAY, HEAD, DEMAND, COMMUNITIES & GENDER, IN THE AMOUNT OF $299,551. SCHEDULE J, PART II, COLUMN (B)(III): OTHER REPORTABLE COMPENSATION - THIS INCLUDES ALLOWANCES DUE TO EMPLOYEES UNDER GAVI'S HR POLICY, INCLUDING ALLOWANCES FOR RELOCATION, EDUCATION GRANT AND REIMBURSEMENT OF NON-SWISS TAXES ON GAVI INCOME. GAVI'S REPORTED COMPENSATION, AS VALUED IN SWISS FRANCS (CHF) IS: A | BASE COMPENSATION B | BONUS AND INCENTIVE "OTHER REPORTED COMPENSATION" INCLUDES THE FOLLOWING: C | US TAX REIMBURSEMENT D | EDUCATION GRANT E | OTHER BENEFITS, INCLUDING SEVERANCE PAYMENTS F | RETIREMENT PLAN G | NONTAXABLE HEALTH INSURANCE DR. SETH BERKLEY 2022 | A) 399,756, B) 15,702, C) 208,423, D) 48,400 E) 18,000, F) 90,086, G) 19,500 2023 | A) 256,025, B) 0, C) 108,923, D) 0, E) 92,638, F) 57,696, G) 14,663 BRENDA KILLEN 2022 | A) 189,156, B) 7,317, C) 0, D) 48,400 E) 0, F) 40,479, G) 13,428 2023 | A) 192,934, B) 0, C) 0, D) 24,200, E) 0, F) 41,491, G) 13,668 ASSIETOU DIOUF 2022 | A) 214,058, B) 4,245, C) 0, D) 0, E) 0, F) 46,982, G) 19,364 2023 | A) 214,064, B) 0, C) 0, D) 0, E) 0, F) 46,982, G) 10,008 ANURADHA GUPTA 2022 | A) 224,402, B) 15,595, C) 0, D) 0, E) 58,856, F) 50,569, G) 8,724 2023 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. THABANI MAPHOSA 2022 | A) 206,180, B) 4,088, C) 0, D) 24,200, E) 0, F) 44,884, G) 16,896 2023 | A) 216,190, B) 0, C) 0, D) 24,200, E) 0, F) 47,538, G) 17,148 PASCAL BAROLLIER 2022 | A) 246,573, B) 4,890, C) 0, D) 0, E) 0, F) 55,411, G) 24,720 2023 | A) 252,038, B) 0, C) 0, D) 0, E) 0, F) 56,797, G) 25,020 MARIE-ANGE SARAKA-YAO 2022 | A) 252,677, B) 10,007, C) 0, D) 0, E) 0, F) 56,941, G) 4,944 2023 | A) 258,011, B) 8,560, C) 0, D) 0, E) 0, F) 58,144, G) 5,004 ANDREW MENDS 2022 | A) 207,710, B) 4,122, C) 0, D) 48,400, E) 0, F) 45,310, G) 13,428 2023 | A) 211,895, B) 0, C) 0, D) 48,400, E) 0, F) 46,443, G) 13,668 DAVID MARLOW 2022 | A) 119,360, B) 0, C) 8,903, D) 0, E) 28,334, F) 26,747, G) 8,462 2023 | A) 263,797, B) 0, C) 137,232, D) 0, E) 0, F) 55,716, G) 16,511 DERRICK SIM 2022 | A) 194,615, B) 3,595, C) 0, D) 0, E) 0, F) 40,803, G) 20,376 2023 | A) 205,756, B) 0, C) 0, D) 0, E) 0, F) 44,417, G) 20,016 HANAH BURRIS 2022 | A) 177,674, B) 3,343, C) 51,696, D) 72,600, E) 0, F) 37,542, G) 13,428 2023 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. AURELIA NGUYEN 2022 | A) 218,948, B) 9,848, C) 0, D) 0, E) 0, F) 49,341, G) 7,472 2023 | A) 258,011, B) 3,311, C) 0, D) 0, E) 0, F) 58,144, G) 8,664 CATHERINE PAWLOW 2022 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2023 | A) 224,326, B) 5,608, C) 0, D) 0, E) 251,614, F) 49,609, G) 10,008 SUSAN MACKAY 2022 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2023 | A) 79,709, B) 0, C) 0, D) 0, E) 250,901, F) 16,378, G) 5,004 ALEX DE JONQUIERES 2022 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2023 | A) 215,998, B) 3,949, C) 0, D) 48,400, E) 0, F) 47,472, G) 13,668 EDMOND GROVE 2022 | A) 208,854, B) 4,141, C) 0, D) 48,400, E) 0, F) 45,621, G) 13,428 2023 | A) 213,350, B) 0, C) 0, D) 61,542, E) 0, F) 46,762 G) 13,668 THE CHF-USD EXCHANGE RATE IS 1.0495 IN 2022 AND 1.1149 IN 2023. ALL OF GAVI ALLIANCE'S HIGHEST COMPENSATED EMPLOYES ARE BASED IN GENEVA, SWITZERLAND. THESE EMPLOYEES' SALARIES REFLECTED THE COST OF LIVING IN GENEVA AND INCLUDE BENEFITS SUCH AS EDUCATION GRANT AND US TAX REIMBURSEMENT. THE BENEFITS PROVIDED TO EMPLOYEES ARE COMPARABLE TO THOSE PROVIDED BY OTHER INTERNATIONAL NON-FOR-PROFIT ORGANISATIONS. X 45006060 309627599 FMV 0 1 0 PART I, COLUMN (B): GAVI REPORTS THE NUMBER OF DOSES IN COLUMN (B). FORM 990, BOX 5: GAVI IS AN INDEPENDENT NON-PROFIT FOUNDATION WITHIN THE MEANING OF ARTICLES 80 ET SEQ. OF THE SWISS CIVIL CODE. IT IS REGISTERED AT THE REGISTRY OF COMMERCE OF THE CANTON OF GENEVA AND PLACED UNDER THE SUPERVISION OF THE SWISS SUPERVISORY BOARD FOR FOUNDATIONS. FORM 990, PART I, LINE 1: GAVI, THE VACCINE ALLIANCE IS A PUBLIC-PRIVATE PARTNERSHIP THAT HELPS VACCINATE MORE THAN HALF THE WORLD'S CHILDREN AGAINST SOME OF THE WORLD'S DEADLIEST DISEASES. THE VACCINE ALLIANCE BRINGS TOGETHER DEVELOPING COUNTRY AND DONOR GOVERNMENTS, THE WORLD HEALTH ORGANIZATION, UNICEF, THE WORLD BANK, THE VACCINE INDUSTRY, TECHNICAL AGENCIES, CIVIL SOCIETY, THE BILL & MELINDA GATES FOUNDATION AND OTHER PRIVATE SECTOR PARTNERS. SINCE ITS INCEPTION IN 2000, GAVI HAS HELPED TO IMMUNISE A WHOLE GENERATION OVER 1 BILLION CHILDREN AND PREVENTED MORE THAN 17.3 MILLION FUTURE DEATHS, HELPING TO HALVE CHILD MORTALITY IN 78 LOWER-INCOME COUNTRIES. GAVI ALSO PLAYS A KEY ROLE IN IMPROVING GLOBAL HEALTH SECURITY BY SUPPORTING HEALTH SYSTEMS AS WELL AS FUNDING GLOBAL STOCKPILES FOR EBOLA, CHOLERA, MENINGOCOCCAL AND YELLOW FEVER VACCINES. AFTER TWO DECADES OF PROGRESS, GAVI IS NOW FOCUSED ON PROTECTING THE NEXT GENERATION, ABOVE ALL THE ZERO-DOSE CHILDREN WHO HAVE NOT RECEIVED EVEN A SINGLE VACCINE SHOT. THE VACCINE ALLIANCE EMPLOYS INNOVATIVE FINANCE AND THE LATEST TECHNOLOGY FROM DRONES TO BIOMETRICS TO SAVE LIVES, PREVENT OUTBREAKS BEFORE THEY CAN SPREAD AND HELP COUNTRIES ON THE ROAD TO SELF-SUFFICIENCY. FORM 990, PART III, LINE 3 COVAX CLOSED ON 31 DECEMBER 2023, AFTER HAVING DELIVERED NEARLY 2 BILLION COVID-19 VACCINE DOSES AND SAFE INJECTION DEVICES TO 146 ECONOMIES, AND IS ESTIMATED TO HAVE AVERTED OVER 2.7 MILLION DEATHS IN AMC LOWER-INCOME PARTICIPATING ECONOMIES. FORM 990, PART I, LINE 5: PART I, LINE 5 LISTS THE TOTAL NUMBER OF EMPLOYEES BASED IN WASHINGTON, DC AND WHO RECEIVED THE FORM W-2. IT DOES NOT INCLUDE FOREIGN AND US CITIZEN EMPLOYEES BASED IN GENEVA, SWITZERLAND. THE TOTAL NUMBER OF EMPLOYEES, INCLUDING US CITIZEN EMPLOYEES BASED IN GENEVA AND WASHINGTON, DC, IS 407. FORM 990, PART VI, SECTION B, LINE 11B THE OUTSOURCED ACCOUNTANT (OA), IN COLLABORATION WITH THE SENIOR MANAGER OF FINANCIAL REPORTING (SMFR), GATHERS ALL INFORMATION NEEDED TO PREPARE THE FEDERAL FORM 990 FROM THE RESPECTIVE GAVI DEPARTMENTS. OA THEN PREPARES THE DRAFT FEDERAL FORM 990 AND PROVIDES IT TO THE SMFR AND GAVI HEAD OF FINANCIAL REPORTING, ACCOUNTING AND CONTROLLING (HFRAC) FOR REVIEW. THE HFRAC REVIEWS THE DRAFT FEDERAL FORM 990 AND DISCUSSES ANY NECESSARY CHANGES WITH THE OA AND SMFR. THE OA THEN SUBMITS THE DRAFT FEDERAL FORM 990 TO THE TAX FIRM FOR REVIEW AND DISCUSSES ANY NECESSARY UPDATES PROVIDED BY THE TAX FIRM, AFTER WHICH THE DRAFT FEDERAL FORM 990 IS UPDATED BY THE OA. THE SMFR THEN CIRCULATES THE UPDATED DRAFT FEDERAL FORM 990 TO VARIOUS GAVI TEAMS FOR THEIR REVIEW AND COMMENT. THE DRAFT FEDERAL FORM 990 IS UPDATED FOR COMMENTS RECEIVED AS DEEMED NECESSARY BY THE HFRAC. THE DRAFT FEDERAL FORM 990, INCLUDING ALL REQUIRED SCHEDULES, IS PROVIDED TO THE AUDIT AND FINANCE COMMITTEE. A GAVI AUTHORIZED REPRESENTATIVE SIGNS THE FEDERAL FORM 990 AFTER WHICH IT IS FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE GOVERNANCE TEAM CIRCULATES THE CONFLICT OF INTEREST DISCLOSURE FORMS TO THE BOARD MEMBERS ANNUALLY. GOVERNANCE MONITORS DISCLOSURE FORMS BY COLLECTING ALL CONFLICT OF INTEREST DISCLOSURES FROM BOARD MEMBERS. THE POLICY IS MONITORED BY THE BOARD OF DIRECTORS ITSELF, AND RELEVANT CONFLICTS ARE DISCLOSED AT THE BOARD OF DIRECTORS MEETINGS AND NOTED IN THE MINUTES. DECLARATIONS OF INTERESTS OF PARTICIPATING BOARD AND COMMITTEE MEMBERS ARE ALSO SHARED AS PART OF THE ADVANCE MATERIAL FOR EACH MEETING. A BOARD MEMBER/ALTERNATE BOARD MEMBER OR COMMITTEE DELEGATE IS EXPECTED TO DISCLOSE ANY REAL/PERCEIVED OR POTENTIAL CONFLICT TO THE CHAIR OF THE BOARD OR THE COMMITTEE, AS SOON AS POSSIBLE UPON LEARNING OF IT AND NO LATER THAN AT THE BEGINNING OF THE DISCUSSION OF THE PERTINENT AGENDA ITEM DURING A BOARD/COMMITTEE MEETING. IT IS THE PREROGATIVE OF THE CHAIR OF THE MEETING, IN CONSULTATION WITH THE GENERAL COUNSEL AND DIRECTOR OF GOVERNANCE, TO DETERMINE THE SCOPE AND LEVEL OF A CONFLICTED PERSON'S PARTICIPATION IN THE DISCUSSION AND THE NECESSITY OF RECUSAL FROM VOTING GIVEN THE TYPE OF INTEREST DISCLOSED. RECUSALS AND/OR ABSTENTIONS FROM ANY DISCUSSIONS AND VOTES ARE NOTED IN THE MINUTES OF THE RELEVANT MEETING. FORM 990, PART VI, SECTION B, LINE 15 GAVI'S COMPENSATION AIMS TO ATTRACT, ENGAGE, REWARD AND RETAIN A TEAM OF HIGH PERFORMING EMPLOYEES WHO ARE DEDICATED TO GAVI'S MISSION. A SYSTEMATIC AND RIGOROUS PROCESS IS SET FOR THE DETERMINATION OF STARTING SALARIES FOR STAFF AT GAVI. KEY CRITERIA FOR ALL POSITIONS INCLUDE THE ASSESSMENT AND SUITABILITY OF THE CANDIDATE AGAINST THE ROLE, INTERNAL EQUITY, AS WELL AS EXTERNAL MARKET COMPETITIVENESS. STARTING SALARIES ARE PREPARED BY THE COMPENSATION AND BENEFITS FUNCTION, APPROVED BY THE CHIEF PEOPLE OFFICER, AND THEN BY THE RESPONSIBLE SENIOR LEADERSHIP MEMBER OR CEO, AS THE CASE MAY BE. GAVI WAS THE FIRST INTERNATIONAL ORGANISATION TO BE CERTIFIED AS EQUAL SALARY CERTIFIED IN 2018, AFTER A RIGOROUS EXTERNAL AUDIT PROCESS WITH THE EQUAL SALARY FOUNDATION IN SWITZERLAND. GAVI CONTINUES TO BE CERTIFIED AS AN EQUAL SALARY EMPLOYER EVERY YEAR SINCE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNANCE DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE POSTED ON THE GAVI ALLIANCE WEBSITE. FORM 1023 AND FEDERAL FORM 990 ARE MADE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART VII, SECTION A: AN ALTERNATE MEMBER CAN VOTE ONLY WHEN THE CORRESPONDING PRIMARY BOARD MEMBER IS UNABLE TO PARTICIPATE IN VOTING. IF THE PRIMARY BOARD MEMBER IS ABLE TO SUBMIT HIS/HER VOTE THEN THE ALTERNATE MEMBER'S VOTE IS NOT REQUIRED. PART VII LISTS 53 VOTING BOARD MEMBERS. HOWEVER ONLY 28 VOTES COULD BE CAST WHICH ARE PRINCIPAL BOARD MEMBERS. THE 25 ALTERNATE BOARD MEMBERS COULD NOT VOTE UNLESS THEIR ASSOCIATED PRINCIPAL BOARD MEMBER WAS UNAVAILABLE TO VOTE. NONE OF THE ALTERNATE BOARD MEMBER SEATS WERE VACANT. FORM 990, PART XI, LINE 9: RETURN OF UNSPENT FUNDS 2,203,563. RECOVERY OF PRIOR YEAR GRANT 52,788,216. INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY CARPENTER COURT 1 MAPLE ROAD BRAM STOCKPORT CHESHIRE UK SK7 2DH RAISES FUNDS FOR IMMUNIZATION PROGRAMS AND PROCUREMENT UK 501(C)(3) FOREIGN CHARITY GAVI ALLIANCE 1 IFFIM SUKUK COMPANY III LIMITED PO BOX 1093 QUEENSGATE HOUSE GRAND CAYMAN CJ KY1-1102 ISSUING SUKUK CERTIFICATES IN SUPPORT OF IFFIM'S OPERATIONS CJ INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION 1 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 0 1 0 0 INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY C 377735536 COST INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY L 116819 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY N 239676 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY O 858622 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY Q 598735 COST